{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vasomotor+Symptoms+Associated+With+Menopause", "query": { "condition": "Vasomotor Symptoms Associated With Menopause" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Vasomotor+Symptoms+Associated+With+Menopause&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-11T04:16:34.042Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01101841", "title": "24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hot Flashes" ], "interventions": [ { "name": "Brisdelle (paroxetine mesylate)", "type": "DRUG" }, { "name": "Placebo capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Noven Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "FEMALE", "summary": "40 Years and older · Female only" }, "enrollment_count": 570, "start_date": "2010-03", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2015-10-15", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 32, "location_summary": "Montgomery, Alabama • Chandler, Arizona • San Diego, California + 28 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01101841" }, { "nct_id": "NCT01890109", "title": "Study of Erenumab (AMG 334) in Women With Hot Flashes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Vasomotor Symptoms; Hot Flashes" ], "interventions": [ { "name": "Erenumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "45 Years to 65 Years · Female only" }, "enrollment_count": 103, "start_date": "2013-05-13", "completion_date": "2014-03-11", "has_results": true, "last_update_posted_date": "2019-01-14", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 7, "location_summary": "San Diego, California • Miami, Florida • Winston-Salem, North Carolina + 3 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01890109" }, { "nct_id": "NCT00314964", "title": "Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hot Flashes" ], "interventions": [ { "name": "PD-0299685", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "40 Years to 70 Years · Female only" }, "enrollment_count": 527, "start_date": "2006-08", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2011-03-16", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 56, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Jonesboro, Arkansas + 41 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00314964" }, { "nct_id": "NCT00369434", "title": "Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Menopause", "Vasomotor System" ], "interventions": [ { "name": "Desvenlafaxine succinate sustained-release (DVS SR)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 450, "start_date": "2006-06", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2007-06-01", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 34, "location_summary": "Montgomery, Alabama • Peoria, Arizona • Upland, California + 31 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Upland", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Brooksville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00369434" }, { "nct_id": "NCT01361308", "title": "Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Postmenopausal Symptoms" ], "interventions": [ { "name": "Brisdelle (paroxetine mesylate)", "type": "DRUG" }, { "name": "Placebo capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Noven Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "FEMALE", "summary": "40 Years and older · Female only" }, "enrollment_count": 614, "start_date": "2011-05", "completion_date": "2012-02", "has_results": true, "last_update_posted_date": "2015-10-15", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 74, "location_summary": "Mobile, Alabama • Chandler, Arizona • Glendale, Arizona + 63 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01361308" }, { "nct_id": "NCT00238732", "title": "Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vaginal Atrophy" ], "interventions": [ { "name": "Bazedoxifene/Conjugated Estrogen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "40 Years to 65 Years · Female only" }, "enrollment_count": 650, "start_date": "2005-10", "completion_date": "2007-03", "has_results": false, "last_update_posted_date": "2007-12-28", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 63, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Scottsdale, Arizona + 60 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00238732" }, { "nct_id": "NCT05042362", "title": "A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vasomotor Symptoms Associated With Menopause", "Hot Flashes" ], "interventions": [ { "name": "Elinzanetant (BAY3427080)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "40 Years to 65 Years · Female only" }, "enrollment_count": 396, "start_date": "2021-08-27", "completion_date": "2023-11-27", "has_results": true, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 55, "location_summary": "Birmingham, Alabama • Mesa, Arizona • Scottsdale, Arizona + 47 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05042362" }, { "nct_id": "NCT07490431", "title": "An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Symptoms in United States", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Vasomotor Symptoms (VMS) Associated With Menopause" ], "interventions": [ { "name": "No intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 1500, "start_date": "2026-06-30", "completion_date": "2029-06-30", "has_results": false, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 1, "location_summary": "Whippany, New Jersey", "locations": [ { "city": "Whippany", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07490431" }, { "nct_id": "NCT05030584", "title": "A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vasomotor Symptoms Associated With Menopause", "Hot Flashes" ], "interventions": [ { "name": "Elinzanetant (BAY3427080)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "40 Years to 65 Years · Female only" }, "enrollment_count": 628, "start_date": "2021-08-27", "completion_date": "2024-02-12", "has_results": true, "last_update_posted_date": "2025-12-01", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 36, "location_summary": "Mobile, Alabama • Mesa, Arizona • Garden Grove, California + 30 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Garden Grove", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Pomona", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05030584" }, { "nct_id": "NCT03596762", "title": "A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Menopause", "Hot Flashes", "Night Waking" ], "interventions": [ { "name": "Elinzanetant (BAY3427080)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "40 Years to 65 Years · Female only" }, "enrollment_count": 199, "start_date": "2018-11-20", "completion_date": "2019-11-21", "has_results": true, "last_update_posted_date": "2023-03-10", "last_synced_at": "2026-06-11T04:16:34.042Z", "location_count": 10, "location_summary": "Mesa, Arizona • San Diego, California • Aventura, Florida + 6 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Lake Worth", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03596762" } ] }